Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens.

doi:10.1016/j.eururo.2017.05.009

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens.

European urology - 1 Nov 2017

Nguyen Paul L, Haddad Zaid, Ross Ashley E, Martin Neil E, Deheshi Samineh, Lam Lucia L C, Chelliserry Jijumon, Tosoian Jeffrey J, Lotan Tamara L, Spratt Daniel E, Stoyanova Radka S, Punnen Sanoj, Ong Kaye, Buerki Christine, Aranes Maria, Kolisnik Tyler, Margrave Jennifer, Yousefi Kasra, Choeurng Voleak, Davicioni Elai, Trock Bruce J, Kane Christopher J, Pollack Alan, Davis John W, Feng Felix Y, Klein Eric A

Abstract excerpt

BACKGROUND: Decipher is a validated genomic classifier developed to determine the biological potential for metastasis after radical prostatectomy (RP). OBJECTIVE: To evaluate the ability of biopsy Decipher to predict metastasis and Prostate cancer-specific mortality (PCSM) in primarily intermediate- to high-risk patients treated with RP or radiation therapy (RT). DESIGN, SETTING, AND PARTICIPANTS: Two hundred and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Androgen Antagonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biopsy, Needle

Share to Bone Neoplasms

Share to Chemoradiotherapy

Share to Databases, Factual

Share to Feasibility Studies

Share to Prostatectomy

Share to Tertiary Care Centers

Source

Open in PubMed

Identifiers

PMID: 28528811
DOI: 10.1016/j.eururo.2017.05.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens.PMID 28528811Read ↗

Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer.Semantic proximity Read ↗

Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patientsSemantic proximity Read ↗

Integration of genomic classification and clinical characteristics predicts survival in metastatic prostate cancerSemantic proximity Read ↗

Gene Signature for Predicting Metastasis in Prostate Cancer Using Primary Tumor Expression ProfilesSemantic proximity Read ↗

Multimodal Radiogenomic Machine Learning for Biochemical Recurrence Prediction Following Radical Prostatectomy Using PSMA-PET, mpMRI, and the Decipher Genomic ClassifierSemantic proximity Read ↗

Prognostic Significance of Circulating Tumor DNA in Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate Cancer.Semantic proximity Read ↗

Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with <i>de novo</i> metastatic diseaseSemantic proximity Read ↗

Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive diseaseSemantic proximity Read ↗

Can We Predict Prostate Cancer Metastasis Based on Biomarkers? Where Are We Now?Semantic proximity Read ↗

A five‐microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell‐free urineSemantic proximity Read ↗

Evolving transcriptomic fingerprint based on genome-wide data as prognostic tools in prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.